标普和纳斯达克内在价值 联系我们

Item 9 Labs Corp. INLB OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Item 9 Labs Corp. (INLB) 是一家上市公司 属于 医疗保健 板块,经营于 制药 - 专科与仿制药 行业. 公司总部位于 Phoenix, AZ, 美国. 现任CEO为 Jeffrey I. Rassas.

INLB 拥有 IPO日期为 2012-01-25, 97 名全职员工, 在 Other OTC, 市值为 $70.18K.

关于 Item 9 Labs Corp.

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

📍 2727 North 3rd Street, Phoenix, AZ 85004 📞 833 867 6337
公司详情
所属板块医疗保健
细分行业制药 - 专科与仿制药
国家美国
交易所Other OTC
货币USD
IPO日期2012-01-25
首席执行官Jeffrey I. Rassas
员工数97
交易信息
当前价格$0.00
市值$70.18K
52周区间0.0001-0.0001
Beta0.07
ETF
ADR
CUSIP46564C203
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言